SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-16-106392
Filing Date
2016-03-18
Accepted
2016-03-18 17:30:28
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 a16-4816_1s3.htm S-3 1529493
2 EX-5.1 a16-4816_1ex5d1.htm EX-5.1 13786
3 EX-23.2 a16-4816_1ex23d2.htm EX-23.2 3052
4 EX-23.3 a16-4816_1ex23d3.htm EX-23.3 3412
5 GRAPHIC g48161kui001.jpg GRAPHIC 11849
6 GRAPHIC g48161kui002.jpg GRAPHIC 4310
7 GRAPHIC g48161kui003.jpg GRAPHIC 2360
8 GRAPHIC g48161csi001.jpg GRAPHIC 5614
9 GRAPHIC g48161cci001.jpg GRAPHIC 5611
  Complete submission text file 0001104659-16-106392.txt   1592379
Mailing Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1
Business Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-210294 | Film No.: 161517018
SIC: 2834 Pharmaceutical Preparations